Company news
Clearpoint Neuro Inc. (NASDAQ:CLPT) news
Clearpoint Neuro Inc. news releases on 6ix. Latest, Aug 3, 2026: ClearPoint Neuro : Earnings Release Q2 2026
Press releases & updates
ClearPoint Neuro : Earnings Release Q2 2026
August 3, 2026
ClearPoint Neuro Reports Second Quarter 2026 Results
August 3, 2026
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
July 30, 2026
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
July 21, 2026
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
May 26, 2026
ClearPoint Neuro Reports First Quarter 2026 Results
May 13, 2026
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
May 13, 2026
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
April 29, 2026
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
April 22, 2026
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint
April 19, 2026
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results
March 16, 2026
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026
March 5, 2026
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe
January 22, 2026
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
January 12, 2026
ClearPoint Neuro Completes Acquisition of IRRAS
November 19, 2025
ClearPoint Neuro Reports Third Quarter 2025 Results
November 5, 2025
ClearPoint Neuro Announces Agreement to Acquire IRRAS
November 5, 2025
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
November 4, 2025
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
October 6, 2025
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
October 5, 2025
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
September 30, 2025
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
September 25, 2025
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
September 24, 2025
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
September 3, 2025
ClearPoint Neuro Reports Second Quarter 2025 Results
August 11, 2025
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
August 3, 2025
ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025
July 22, 2025
ClearPoint Neuro Reports First Quarter 2025 Results
May 12, 2025
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing
May 11, 2025
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
April 27, 2025
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
April 24, 2025
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
April 24, 2025
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
April 23, 2025
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
February 25, 2025
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
February 13, 2025
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
February 11, 2025
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
January 26, 2025
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
November 12, 2024
ClearPoint Neuro Reports Third Quarter 2024 Results
November 6, 2024
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024
October 30, 2024
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
October 16, 2024
ClearPoint Neuro Announces Early Repayment of $10 Million Note
August 25, 2024
ClearPoint Neuro Reports Second Quarter 2024 Results
August 6, 2024
ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
July 16, 2024
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
June 19, 2024
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
May 31, 2024
ClearPoint Neuro Reports First Quarter 2024 Results
May 6, 2024
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
May 1, 2024
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
April 28, 2024
ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
April 23, 2024